Kalvista Pharmaceuticals Inc (KALV)

Total Costs & Expenses

$71.44M

Quarterly · Period ending: · USD

KALV logo

KALV Total Costs & Expenses

Latest reported$71.44M
KALV Quarterly Total Costs & Expenses ($1.48M → $71.44M)
High-resolution chart · PNG

KALV total costs & expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Kalvista Pharmaceuticals Inc Total Costs & Expenses — Quarterly (USD)
Period endingTotal Costs & Expenses (USD)
71,436,500
64,305,000
59,742,000
60,435,000
55,030,000
42,940,000
45,811,000
44,215,000
48,455,000
33,151,000
29,746,000
29,093,000
31,728,000
26,945,000
25,883,000
26,316,000
26,811,000
26,683,000
23,603,000
19,516,000
18,042,000
12,657,000
12,781,000
14,443,000
12,781,000
14,301,000
13,209,000
12,933,000
14,186,000
10,550,000
10,485,000
10,727,000
7,809,000
6,677,000
7,064,000
5,549,000
5,200,000
8,365,000
2,412,000
2,412,000
5,075,000
5,577,000
4,906,000
5,674,000
4,908,000
3,825,000
3,578,000
2,441,000
1,862,000
1,484,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.